Honors College Senior Thesis Presentations

The Effects of Hallucinogenic Drugs in the Treatment of Mental Health Disorders

Presenter Information

Brianna GagenFollow

Academic Level at Time of Presentation

Senior

Major

Biology/Pre-Medicine

Minor

Chemistry

List all Project Mentors & Advisor(s)

Dr. J Ricky Cox

Presentation Format

Oral Presentation

Abstract/Description

The rates of mental health disorders in the United States have skyrocketed over the past decade. With stigma surrounding the discussion of mental health and the symptoms associated with it, often those that are suffering do not receive sufficient treatment, as they might with a physical illness. The current, common treatment options for common psychological disorders, like depression, anxiety, and post-traumatic stress disorder, are sometimes not effective in patients, due to resistance or poor response outcomes. Consequently, in order to research alternative therapeutic approaches for mental health disorders, scientists are researching the effects of several hallucinogenic drugs in controlled clinical environments as options. Drugs such as MDMA, psilocybin, LSD, and ketamine are socially prohibited by law; however, some of their benefits and mechanisms of action might have positive effects on treating the disorders of the brain. This thesis provides a summary of mental illness, hallucinogenic drugs, and the ongoing research regarding the use of these drugs in mental health treatment. While the negative connotation around hallucinogenic drugs remains, researchers are proving that they might have value in medicine, but the question remains of if science and society are ready to implement controlled hallucinogenic drug therapies into mental health treatment based on the present research. The exploration of this question and suggested integration strategies will be included in this thesis.

Location

Waterfield Gallery

Start Date

17-11-2021 11:30 AM

End Date

17-11-2021 12:30 PM

Fall Scholars Week 2021 Event

Honors Senior Presentations

This document is currently not available here.

Share

COinS
 
Nov 17th, 11:30 AM Nov 17th, 12:30 PM

The Effects of Hallucinogenic Drugs in the Treatment of Mental Health Disorders

Waterfield Gallery

The rates of mental health disorders in the United States have skyrocketed over the past decade. With stigma surrounding the discussion of mental health and the symptoms associated with it, often those that are suffering do not receive sufficient treatment, as they might with a physical illness. The current, common treatment options for common psychological disorders, like depression, anxiety, and post-traumatic stress disorder, are sometimes not effective in patients, due to resistance or poor response outcomes. Consequently, in order to research alternative therapeutic approaches for mental health disorders, scientists are researching the effects of several hallucinogenic drugs in controlled clinical environments as options. Drugs such as MDMA, psilocybin, LSD, and ketamine are socially prohibited by law; however, some of their benefits and mechanisms of action might have positive effects on treating the disorders of the brain. This thesis provides a summary of mental illness, hallucinogenic drugs, and the ongoing research regarding the use of these drugs in mental health treatment. While the negative connotation around hallucinogenic drugs remains, researchers are proving that they might have value in medicine, but the question remains of if science and society are ready to implement controlled hallucinogenic drug therapies into mental health treatment based on the present research. The exploration of this question and suggested integration strategies will be included in this thesis.